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FlavonolAbstract On continuation of the phytochemical investigation of the MeOH extract of Cyperus
rotundus L. Rhizomes, four compounds namely, methyl 3,4-dihydroxy benzoate (1), ipolamiide
(2), 6b-hydroxyipolamiide (3), and rutin (4) were isolated. Their structures were established on
the basis of 1D and 2D NMR spectroscopic analyses as well as ESIMS spectral data. Compounds
2 and 3 are reported here for the ﬁrst time from the genus Cyperus and 1 for the ﬁrst time from the
plant. Co-treatment of CCl4 hepatic injured rats with the total MeOH extract (TME) and EtOAc
fraction signiﬁcantly restored the hepatic marker enzymes and total bilirubin to near-normal values
compared to silymarin (reference drug).
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Cyperus rotundus L. (Nutgrass, family Cyperaceae) is widely
distributed in many tropical and subtropical regions of the
world.1 In the Egyptian folk medicine, its tubers are used as
anthelmintic, aphrodisiac, diuretic, sedative, carminative, stim-
ulant, tonic, and stomachic.1 Also, they are used as a remedy
for renal colic and dysentery.2 Furthermore, the plant pos-
sesses different biological activities such as antioxidant,3–5
cytotoxic,3,5 anti-allergic,6,7 antipyretic, anti-inﬂammatory,
antiemetic, hypotensive,8 anticonvulsant,9 anti-malarial,
antimicrobial,10,11 anti-diarrhoeal,12 anti-diabetic,5,13,14
hepatoprotective,14,15 and insecticide.16,17 The previous phyto-
chemical studies of C. rotundus L. led to the isolation of sesqui-
terpenes,13,18–23 ﬂavonoids,3,5,8,24,25 phenylpropanoids,5,26,27phenolic acids,5,26 alkaloids,28 and saponins.29 In 2013 Zhou
and Zhang reported the isolation of iridoid glycosides from
C. rotundus rhizomes.27 This prompted further investigation
of the EtOAc fraction of the MeOH extract of C. rotundus
rhizomes aiming to isolate iridoids. The present work reports
the isolation and identiﬁcation of methyl 3,4-dihydroxy benzo-
ate (1), ipolamiide (2), 6b-hydroxyipolamiide (3), and rutin (4)
(Fig. 1). TME and EtOAc fraction were tested for their hepa-
toprotective activity against CCl4-induced hepatic injury.
2. Experimental
2.1. General procedures
The ESIMS spectra were recorded on a Finnigan MATTSQ-
7000 triple stage quadrupole mass spectrometer (Thermo Finn-
igan, Bremen, Germany). 1D and 2D NMR spectra (chemical
shifts in ppm, coupling constants in Hz) were recorded on a
Bruker DRX400 NMR spectrometer using CD3OD and
Figure 1 Structures of the isolated compounds 1–4.
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(Bruker, Rheinstetten, Germany). Solvents were distilled prior
to use and spectral grade solvents were used for spectroscopic
measurements. Column chromatographic separations were
performed on silica gel 60 (0.04–0.063 mm, Merck, Darmstadt,
Germany). TLC was performed on precoated TLC plates with
silica gel 60 F254 (layer thickness 0.2 mm, Merck). The com-
pounds were detected by spraying with p-anisaldehyde/
H2SO4 reagent and heating at 110 C for 1–2 min. Silymarin
was purchased from Sigma–Aldrich chemical Co. (St. Louis,
MO, USA).
2.2. Plant material
The rhizomes of C. rotundus L. were collected in June 2009
from plants growing in the campus of Al-Azhar University,
Assiut Branch, Egypt. The plant was kindly identiﬁed by Salah
El-Nagar, Professor of Plant Taxonomy, Faculty of Science,
Assiut University, Assiut, Egypt. A voucher sample (2009-
CR110) was kept in the Herbarium of the Pharmacognosy
Department, Faculty of Pharmacy, Al-Azhar University,
Assiut, Egypt.
2.3. Extraction and isolation
The fresh rhizomes (1.2 kg) were cut and defatted using n-hex-
ane (3 · 2 L), then extracted with MeOH (4 · 2 L). The MeOH
extract was evaporated and concentrated under reduced pres-
sure to afford a dark brown residue (14.1 g). The latter was
subjected to VLC (vacuum liquid chromatography) usingn-hexane/EtOAc and EtOAc/MeOH gradients to afford ﬁve
fractions: CR-I to CR-V: CR-I (2.3 g, n-hexane/EtOAc
75:25%), CR-II (1.9 g, n-hexane/EtOAc 50:50%), CR-III
(2.1 g, n-hexane/EtOAc 25:75%), CR-IV (1.8 g, EtOAc
100%), and CR-V (5.2 g, MeOH 100%). The fraction CR-IV
(1.8 g) was subjected to silica gel column chromatography
(80 g · 50 · 2 cm) using CHCl3/MeOH gradient to give ﬁve
major sub-fractions CR-IV-A to CR-IV-E. Silica gel column
chromatography (80 g · 50 · 2 cm) of sub-fraction CR-IV-B
(175 mg) using n-CHCl3/MeOH as an eluent gave compound
1 (11 mg, brown residue). Sub-fraction CR-IV-C (195 mg)
was chromatographed over silica gel column
(80 g · 50 · 2 cm) using CHCl3/MeOH gradient to obtain 2
(4.3 mg, white amorphous powder). Sub-fraction CR-IV-D
(411 mg) was chromatographed on silica gel column using
CHCl3/MeOH gradient to afford 3 (5.1 mg, white amorphous
powder). Silica gel column chromatography
(100 g · 50 · 2 cm) of sub-fraction CR-IV-E (350 mg) using
CHCl3/MeOH as an eluent gave 4 (18 mg, yellow amorphous
powder).
Methyl-3,4-dihydroxy benzoate (1): It was isolated as a
brown residue (11 mg). ESIMS: m/z 169 [M+H]+. 1H NMR
(DMSO-d6, 400 MHz): dH 7.42 (1H, d, J = 2.2 Hz, H-2),
6.84 (1H, d, J = 7.6 Hz, H-5), 7.45 (1H, dd, J = 7.6, 2.2 Hz,
H-6), 12.56 (1H, s, 3-OH), 9.88 (1H, s, 4-OH). 13C NMR
(DMSO-d6, 100 MHz): dC 121.6 (s, C-1), 112.7 (d, C-2),
147.2 (s, C-3), 151.1 (s, C-4), 115.0 (d, C-5), 123.5 (d, C-6),
167.2 (s, C-7), 55.5 (q, 7-OCH3).
30
Rutin (4): It was isolated as a yellow amorphous powder
(18 mg). ESIMS: m/z 611 [M+H]+. 1H NMR (CD3OD,
400 MHz): dH 6.19 (1H, d, J = 1.8 Hz, H-6), 6.38 (1H, d,
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J = 6.8 Hz, H-50), 7.61 (1H, dd, J = 6.8, 1.8 Hz, H-60), 5.11
(1H, d, J = 7.4 Hz, H-100), 4.51 (1H, d, J = 0.6 Hz, H-100 0),
1.11 (3H, d, J = 6.0 Hz, H-600 0), 3.28–3.81 (m, other sugar pro-
tons). 13C NMR (CD3OD, 100 MHz): dC 157.2 (s, C-2), 133.9
(s, C-3), 177.9 (s, C-4), 161.5 (s, C-5), 98.8 (d, C-6), 166.1 (s, C-
7), 92.7 (d, C-8), 156.5 (s, C-9), 105.0 (s, C-10), 121.8 (s, C-10),
115.3 (d, C-20), 145.2 (s, C-30), 148.5 (s, C-40), 116.3 (d, C-50),
121.7 (d, C-60), 101.2 (d, C-100), 74.1 (d, C-200), 76.0 (d, C-300),
70.1 (d, C-400), 76.5 (d, C-500), 67.1 (d, C-600), 100.8 (d, C-100 0),
70.4 (d, C-200 0), 70.6 (d, C-300 0), 71.9 (d, C-400 0), 68.3 (d, C-500 0),
17.3 (q, C-600 0).8,31
2.4. Pharmacological study
2.4.1. Animals
Adult male albino rats weighing 120–150 g were obtained from
the animal facility of Faculty of Pharmacy, King Saud Univer-
sity, Riyadh, KSA. Animals were housed at a temperature of
23 ± 2 C with free access to water and standard food pellets.
Rats were left to acclimatize in the animal facility for 1 week
prior to experimentation. All animal procedures were con-
ducted in accordance with the guidelines of the Institutional
Animal Ethics Committee of King Saud University (approval
number KSU/IAEC/1432/12).
2.4.2. Hepatoprotective activity
The hepatoprotective activity was determined as previously
outlined.32 Rats were randomly divided into ﬁve groups of 6
animals each. The 1st group was given olive oil in an oral dose
of 1 mL/kg of body weight (b.wt) for 5 successive days and
kept as a negative control. Animals of the 2nd group were
given a single oral dose of 50% CCl4 in olive oil (1 mL/kg
b.wt) (positive control). The 3rd group was treated daily with
25 mg/kg b.wt silymarin (a standard drug) for 5 successive
days. The 4th and 5th groups were orally administeredTable 1 NMR data of compound 2 and 3 (CD3OD, 400 and 100 M
No. 2
dH [mult., J (Hz)] dC (mult.) HMBC
1 5.80 brs 93.2 (CH) 10, 3, 5, 8
3 7.43 s 152.1 (CH) 1, 4, 11
4 – 114.8 (C) –
5 – 71.0 (C) –
6 2.25 m 38.1 (CH2) 4, 5, 7, 8
2.08 m 4, 6
7 1.93 m 39.7 (CH2) 5, 6, 8
1.56 m 5, 6, 8, 9
8 – 77.4 (C)
9 2.45 s 60.5 (CH) 1, 4, 5, 8
10 1.14 s 22.1 (CH3) 7, 8, 9
11 – 166.8 (C) –
10 4.57 d (7.4) 99.7 (CH) 1, 30
20 3.65 m 72.8 (CH) –
30 3.36 m 77.0 (CH) 20, 40
40 3.31 m 70.1 (CH) 60
50 3.36 m 76.3 (CH) 20, 40
60 3.16 m 61.8 (CH2) 10, 30
3.23 m
11-OCH3 3.87 s 51.7 (CH3) 11100 mg/kg b.wt of the TME and EtOAc fraction, respectively,
for 5 successive days. Twenty-four hours following the last
dose, rats of the 3rd–5th groups were given a single dose of
50% CCl4 in olive oil (1 mL/kg b.wt, orally). Two days later,
blood samples were obtained from the orbital plexus of each
rat. The serum was obtained by centrifugation at 3000 rpm
for 15 min and serum samples were taken for biochemical
assays, namely glutamate oxaloacetate transaminase (SGOT),
glutamate pyruvate transaminase (SGPT), and Total bilirubin
(TB).
2.4.3. Statistical analysis
The data were expressed as mean SE (n= 6). Results were
analyzed statistically by one-way ANOVA followed by com-
parison using Prism software (Graph Pad. Ver. 3.0).
3. Results and discussion
Compound 2 was obtained as a white amorphous powder. It
had a molecular formula C17H26O11, which was determined
by ESIMS pseudo-molecular ion peak at m/z 407 [M+H]+.
The 13C NMR spectrum of 2 (Table 1) showed 17 carbon sig-
nals, six of which could be assigned to b-glucopyranosyl moi-
ety33 and one for one methoxy group. Their multiplicities were
determined by HMQC experiment. The NMR spectra of 2
(Table 1) exhibited the characteristic signals for an iridoid
structure and showed the existence of a methoxy carbonyl
function (dH 3.87, s)/dC 51.7 (11-OCH3) and 166.8 (C-11),
and a tertiary methyl group (dH 1.14, s, H3-10)/dC 22.1 (C-
10).34,35 In addition, resonances arising from two methylene
groups were observed at dH 2.25 (m, H-6A) and 2.08 (m, H-
6B)/dC 38.1 (C-6), 1.93 (m, H-7A) and 1.56 (m, H-7B)/dC
39.7 (C-7). In addition to, three singlet signals at dH 5.80,
7.43, and 2.45 were attributed to H-1, H-3, and H-9, respec-
tively. They correlated with the carbons resonating at dC
93.2 (C-1), 152.1 (C-3), and 60.5 (C-9) in the HMQC spectrum.Hz).
3
dH [mult., J (Hz)] dC (mult.) HMBC
5.83 brs 93.5 (CH) 10, 3, 5, 6
7.48 s 153.1 (CH) 1, 4, 5, 11
– 113.8 (C) –
– 70.1 (C) –
4.03 dd (6.8, 5.1) 75.8 (CH) 4, 8, 9
1.98 m 47.5 (CH2) 1, 5, 6, 9
, 10 1.87 m
– 78.2 (C)
, 10 2.55 s 60.2 (CH) 1, 4, 5, 6
1.12 s 23.2 (CH3) 6, 7, 8, 9
– 167.0 (C) –
4.57 d (7.6) 99.8 (CH) 1, 30
3.72 m 73.0(CH) –
3.39 m 77.5 (CH) 20, 40
3.34 m 70.2 (CH) 60
3.41 m 76.5 (CH) 20, 40
3.19 m 62.5 (CH2) 1
0, 30
3.22 m
3.72 s 51.6 (CH3) 11
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the anomeric proton of b-glucopyranose unit.33 It correlated
with the anomeric carbon resonating at dC 99.7 (C-1) in the
HMQC spectrum. The downﬁeld shift of the H-1 signal (dH
5.80), indicated the attachment of the-glucopyranose unit at
the C-1 position of the iridoid aglycone. This was conﬁrmed
by the HMBC cross peaks observed between H-1 at dH 5.80
and anomeric carbon of glucose moiety C-10 at dC 99.7, and
H-10 at dH 4.57 and C-1 (dH 93.2) (Fig. 2). The methoxy car-
bonyl group was assigned to be positioned at C-4 due to the
highly deshielded signal of the H-3. Also, it was secured by
the HMBC cross peak between methoxy group at dH 3.87
and C-11 (dC 166.8) and H-3 and C-11. The multiplicity of
H-9 was also indicative of a totally substituted C-8. However,
the HMBC cross peaks of the tertiary methyl group (dH 1.14,
s) to C-7, C-8 and C-9, suggested its attachment at C-8. By the
complete analysis of the NMR data of 2 and comparison of
these data with those given in the literature,34–37 compound
2 was determined to be ipolamiide, which is reported here
for the ﬁrst time from genus Cyperus.
Compound 3 was isolated as a white amorphous powder
and showed a ESIMS pseudo-molecular ion peak at m/z 423
[M+H]+, which conﬁrmed the molecular formula
C17H26O12. Compound 3 is 16 mass units more than 2, indicat-
ing the presence of an additional hydroxyl group. The NMRFigure 2 Key HMBC correlations of compounds 2 and 3.
Table 2 Effect of TME and EtOAc fraction on the level of liver en
Animal group SGOT (IU/L)
Control (Negative control) 21.17 ± 0.940
CCl4 treated (Positive control) 62.92 ± 2.790
a
Silymarin + CCl4 24.81 ± 1.650
a,b
TME+ CCl4 39.17 ± 2.940
a,b,c
EtOAc fraction + CCl4 32.53 ± 2.910
a,b,c
S.E. = Standard error; n= 6.
a Signiﬁcant from control at P< 0.05.
b Signiﬁcant from CCl4 at P< 0.05.
c Signiﬁcant from silymarin at P< 0.05.data for 2 and 3 were quite similar (Table 1), but the signals
associated with the methylene group at dH 2.25 and 2.08
(H2-6)/dC 38.1 (C-6) found in 2 were not observed in the spec-
tra for 3. Instead, a new signal for oxymethine at dH 4.03 (1H,
dd, J= 6.8, 5.1 Hz, H-6) was observed and correlated to car-
bon signal at dC 75.8 (C-6) in the HMQC spectrum and
showed HMBC correlations to C-4, C-8, and C-9 conﬁrming
its position (Fig. 2). On the basis of these ﬁndings and by com-
parison of the literature data together with those obtained
from NMR spectra,34–37 the structure of 3 was unambiguously
elucidated and determined to be 6b-hydroxyipolamiide and
reported here for the ﬁrst time from genus Cyperus.
Other compounds were identiﬁed as methyl 3,4-dihydroxy
benzoate (1)30 and rutin (4)8,31 by analysis of the spectroscopic
data and comparison of their data with those in the literature.
C. rotundus is known to be a rich source of ﬂavonoids and
phenolic compounds of various biological activities.3,5,8 Oral
CCl4 administration caused liver injury in rats that was mani-
fested by signiﬁcant elevation in the levels of serum hepatic
marker enzymes (SGOT and SGPT) and total bilirubin (TB)
as shown in Table 2. The results revealed a marked elevation
in enzyme activities of group 2 (CCl4-administered rats) when
compared with group 1 (control rats). In comparison with the
CCl4-treated group, signiﬁcant improvements were seen in the
serum activity of SGOT, SGPT, and total bilirubin in rats that
had been previously medicated with silymarin, TME, and
EtOAc fraction (Table 2). The biochemical mechanism of
CCl4 toxicity is based on mitochondrial damage that leads to
an accumulation of fat within 60 min, damage of endoplasmic
reticulum within 30 min, and damage of lysosomes, which
result in death of the hepatocytes.38,39 The observed hepato-
protective effect of C. rotundus against CCl4-hepatotoxicity is
attributed to the presence of ﬂavonoids, which are known to
be hepatoprotective and antioxidants that act as free radical
scavengers for the lipoperoxidants.40 The hepatoprotective
effect of the TME seems to involve the maintaining of the liver
antioxidative defense systems in addition to the scavenging of
reactive oxygen species (ROS) and NO; these lead to an inhi-
bition of lipid peroxidation.41
4. Conclusions
Re-investigation of the MeOH extract of C. rotundus rhizomes
afforded four compounds. Compound 1 is reported for the
ﬁrst time from C. rotundus. While, 2 and 3 were isolated for
the ﬁrst time from genus Cyperus. Their structures were estab-
lished by different spectroscopic analyses. The TME and
EtOAc fraction showed signiﬁcant hepatoprotective activity.zymes in CCl4 treated rats.
SGPT (IU/L) TB (mg/dL)
34.76 ± 0.430 0.57 ± 0.050
45.99 ± 2.910a 1.82 ± 0.207a
31.13 ± 2.110a,b 0.69 ± 0.029a,b
36.79 ± 1.810a,b,c 1.12 ± 0.321a,b,c
34.94 ± 1.490a,b,c 0.91 ± 0.130a,b,c
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None.
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